X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-10-07 | MRNA | Mock James M | CFO | S - Sale+OE | $60.12 | -715 | 9,505 | -7% | -$42,986 | |||||
| D | 2024-08-29 | MRNA | Mock James M | CFO | S - Sale+OE | $78.03 | -162 | 8,767 | -2% | -$12,640 | |||||
| D | 2024-08-28 | MRNA | Mock James M | CFO | S - Sale+OE | $79.39 | -1,321 | 8,600 | -13% | -$104,881 | |||||
| D | 2024-07-08 | MRNA | Mock James M | CFO | S - Sale+OE | $118.24 | -689 | 7,269 | -9% | -$81,465 | |||||
| D | 2024-06-03 | MRNA | Mock James M | CFO | S - Sale+OE | $140.72 | -691 | 6,506 | -10% | -$97,237 | |||||
| D | 2024-05-29 | MRNA | Mock James M | CFO | S - Sale+OE | $144.51 | -183 | 5,871 | -3% | -$26,444 | |||||
| D | 2024-05-28 | MRNA | Mock James M | CFO | S - Sale+OE | $162.47 | -648 | 5,726 | -10% | -$105,283 | |||||
| D | 2024-04-08 | MRNA | Mock James M | CFO | S - Sale+OE | $101.93 | -705 | 5,048 | -12% | -$71,859 | |||||
| D | 2024-02-29 | MRNA | Mock James M | CFO | S - Sale+OE | $94.57 | -647 | 4,300 | -13% | -$61,188 | |||||
| D | 2024-01-08 | MRNA | Mock James M | CFO | S - Sale+OE | $109.76 | -772 | 3,632 | -18% | -$84,731 | |||||
| D | 2023-10-06 | MRNA | Mock James M | CFO | S - Sale+OE | $102.50 | -2,858 | 2,952 | -49% | -$292,953 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |